Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity Active Not Recruiting Phase 1 / 2 Trials for Fludeoxyglucose (18F) (DB09502)

IndicationStatusPhase
DBCOND0029503 (Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs